Skip to main content

Commit To Buy Neumora Therapeutics At $5, Earn 105.2% Annualized Using Options

Investors considering a purchase of Neumora Therapeutics Inc (NMRA) stock, but tentative about paying the going market price of $10.71/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April 2025 put at the $5 strike, which has a bid at the time of this writing of $1.70..
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.